4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-21-000144
EVP, Chief Financial Officer bought 3,000 shares at $37.46 ($112,380)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LINDAHL RICHARD S EVP, Chief Financial Officer | 2021-11-15 | Purchase | +3,000 | $37.46 | $112,380 | 39,919 | D: show line 1 in the form |
| Open-market purchases · 3,000 sh · avg $37.46 · $112,380 | |||||||
Loading xslF345X03/wf-form4_163701676472498.xml…